Of the 71 patients in the study, 42 were men, 53 were Caucasian, 50 had nonischemic cardiomyopathy, and the diagnosis was confirmed in 66 of the 71 patients via cardiac catheterization (n=52) or ...
The therapeutic efficacy of the cardiac glycoside digitoxin in patients with heart failure and reduced ejection fraction is not established. In this international, double-blind, placebo-controlled ...
Ventricular resection can significantly improve your life span if you have severe heart failure due to an enlarged left ventricle. If you have an enlarged heart (also known as cardiomegaly), it means ...
Results from the Phase 3 VICTOR trial and a pooled analysis of the VICTOR and VICTORIA trials were presented today at the ESC Congress 2025 and simultaneously published in The Lancet VERQUVO was ...
Heart failure has historically been irreversible, but the outcome of a new study suggests that could someday change. At the University of Utah, scientists used a new gene therapy that was shown to ...
A new gene therapy can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the amount of blood the heart can pump and dramatically improves ...
Certain heart conditions, including a heart attack, may contribute to an enlarged heart. In these instances, a doctor may recommend left ventricular reconstructive surgery to prevent further ...
UC Health is making history with a groundbreaking cardiac procedure. A team of surgeons performed a world-first operation that could change the way heart failure patients are treated.A team of ...
Alexandria Nyembwe is a registered nurse and health writer. She has worked in street medicine serving populations experiencing homelessness in Skid Row Los Angeles as well as in cardiovascular care in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results